Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Ackman
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by healthstock1234on Oct 27, 2015 12:15pm
108 Views
Post# 24230687

RE:Ackman

RE:AckmanI think it will be on Friday
Bill Ackman, the billionaire activist investor, will discuss his holding in Valeant Pharmaceuticals International Inc. on a conference call with other investors Friday.
https://www.bloomberg.com/news/articles/2015-10-27/top-valeant-holder-bill-ackman-to-discuss-investment-on-call

cg16 wrote: apparently Pershing Square Holdings hosted a conference call this morning to discuss why PSH/Ackman invested in Valeant. Did anyone listen in? or have a link?


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities